truncation issues [General Sta­tis­tics]

posted by Loky do – Egypt, 2020-06-24 05:23 (1794 d 14:23 ago) – Posting: # 21570
Views: 4,678

Hello Dears,

For certain products, ema product-specific bioequivalence guidance states that the main PK variables: AUC0-72,...etc (also stated in the study protocol), Is that mean any subject who miss 72 h will be excluded from AUC0-72 calculations? if yes, there will be around 25% of subjects missed this interval, is that will be acceptable?

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,681 registered users;
61 visitors (0 registered, 61 guests [including 9 identified bots]).
Forum time: 19:47 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5